Compare VFF & ORGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VFF | ORGO |
|---|---|---|
| Founded | 1989 | 1985 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Biotechnology: Pharmaceutical Preparations |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 314.1M | 299.8M |
| IPO Year | 2013 | 2016 |
| Metric | VFF | ORGO |
|---|---|---|
| Price | $2.12 | $2.48 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | ★ 995.0K | 937.0K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 184.38 | ★ 1600.00 |
| EPS | ★ 0.02 | N/A |
| Revenue | $215,937,000.00 | ★ $564,169,000.00 |
| Revenue This Year | $12.19 | N/A |
| Revenue Next Year | $15.82 | $26.27 |
| P/E Ratio | $108.00 | ★ N/A |
| Revenue Growth | N/A | ★ 17.04 |
| 52 Week Low | $1.04 | $2.04 |
| 52 Week High | $4.99 | $7.08 |
| Indicator | VFF | ORGO |
|---|---|---|
| Relative Strength Index (RSI) | 31.13 | 50.15 |
| Support Level | N/A | $2.20 |
| Resistance Level | $3.66 | $2.67 |
| Average True Range (ATR) | 0.11 | 0.14 |
| MACD | -0.04 | -0.01 |
| Stochastic Oscillator | 11.21 | 56.55 |
Village Farms International Inc owns and operates intensive agricultural greenhouse facilities in British Columbia and Texas, where it produces, markets and sells tomatoes, bell peppers and cucumbers. Its wholly owned subsidiary, Pure Sunfarms, is a vertically integrated licensed producer and supplier of cannabis products sold to other licensed providers and provincial governments across Canada and internationally. The Company's wholly owned subsidiary, Balanced Health, develops and sells, cannabidiol (CBD) based products including ingestible, edible and topical applications. The operating segments of the Company are VF Fresh (Produce), Cannabis Canada, Cannabis U.S., Clean Energy, and Cannabis - Netherlands. The company makes majority of its revenue from the Cannabis Canada segment.
Organogenesis Holdings Inc is a regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the advanced wound care, surgical, and sports medicine markets. The company's portfolio of regenerative medicine products in the advanced wound care category includes Apligraf, Dermagraft, PuraPly AM, CYGNUS Dual, etc., and the sports medicine products include NuShield as a surgical barrier and PuraForce as a reinforcement matrix in targeted soft tissue repairs; and Affinity, Novachor, PuraPly MZ, PuraPly AM, and PuraPly SX for management of open wounds in the surgical setting. The company operates in a single segment, that is, regenerative medicine.